Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Synribo, Omacetaxine mepesuccinate (formerly Ceflatonin, Omapro)
Also known as: sHHT (formerly CGX-635, homoharringtonine)
print preview
bookmark
share with colleague
General Information
Company
Teva Pharmaceutical Industries Ltd.
Description
Small molecule that targets the ribosome to inhibit synthesis of oncoproteins
Molecular Target
Cyclin D1 (CCND1) (BCL1)
;
Myeloid leukemia cell differentiation protein (MCL1)
Mechanism of Action
Myeloid leukemia cell differentiation protein (Mcl-1) inhibitor
Latest Stage of Development
Approved
Indication
Chronic myelogenous leukemia (CML)
Partner
Hospira Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy